Recent developments in health and medicine cover pharmaceutical waste, medical technology, and new clinical findings across diverse medical specialties.
Key Points
Pharmacists are urging the NHS to implement more rigorous medication reviews to address the annual waste of medicines valued at 480 million pounds in England.
A clinical study indicates that a bitter hop extract may aid in fat loss among obese adults while preserving muscle mass, despite reports of some gastrointestinal side effects.
The FDA has scheduled an advisory committee meeting for September to evaluate the efficacy of the Galleri multi-cancer screening test developed by Grail.
Research suggests that obesity and advanced age increase the risk of severe toxicity in young patients undergoing induction therapy for acute lymphoblastic leukemia.
A study comparing diagnostic criteria found that simple BMI or waist circumference measurements are as accurate as the more complex Lancet Commission definition for diagnosing obesity.
The MHRA has approved remibrutinib, a new oral BTK inhibitor that provides an alternative treatment option for adults suffering from chronic spontaneous urticaria.
Analysis of hospital data in Germany reveals that official diagnostic codes significantly underrepresent the actual incidence of physical child abuse.
Medical professionals are increasingly utilizing YouTube platforms to conduct patient education and supplement their professional practice income.